A: We utilize engineering to optimize the NAD+-binding pocket, which enhances the thermal and chemical stability of the enzyme during storage and industrial use.

Introduction to UDP-Glucuronic Acid 4-Epimerase

UDP-glucuronic acid 4-epimerase stands as a pivotal NAD⁺-dependent Glycosyl Functional Enzyme within the short-chain dehydrogenase/Reductase (SDR) superfamily, playing a crucial role in various biochemical pathways. This Epimerase facilitates the reversible epimerization of UDP-glucuronic acid (UDP-GlcA) to UDP-galacturonic acid (UDP-GalA), a transformation that is indispensable for the biosynthesis of pectin, a structural polysaccharide found in plant cell walls, and for the functionalization of proteins through glycosylation processes.

Fig.1. The UglcAEs-catalyzed interconversion between UDP-GlcA and UDP-GalA. (OA Literature) Fig.1 The interconversion of UDP-GlcA and UDP-GalA catalyzed by UglcAEs.¹

Service Introduction

Are you currently facing metabolic leakage in your carbohydrate synthesis, low yields in recombinant glycoprotein expression, or difficulties in achieving the precise "mouthfeel" required for alternative protein scaffolds? Creative Biolabs provides end-to-end solutions for the design, expression, and purification of highly specific UDP-glucuronate 4-epimerases (UGAepi). Our service ensures that your project bypasses the "decarboxylation trap" common in sugar-nucleotide metabolism, delivering an enzyme with high fidelity for the conversion of UDP-GlcA to UDP-GalA. Whether you are developing advanced pectic polysaccharides for food-tech or functionalizing therapeutic proteins, our custom service provides the biocatalytic precision necessary for industrial success.

See How Our Services Support Sustainable Practices

UDP-Glucuronic Acid 4-Epimerase Production Workflow

Step 1

In Silico Enzyme Design

Utilizing advanced molecular docking and Rossmann-fold modeling, we predict and enhance the stability of the NAD⁺-binding pocket with high precision.

Outcome: A tailored digital enzyme blueprint optimized for your specific industrial demands.

Step 2

Strain Engineering & Proteostasis Optimization

The carefully designed enzyme sequence is integrated into our proprietary microbial host, such as Pichia pastoris. By overexpressing chaperone networks, we effectively alleviate ER stress.

Outcome: A microbial "super-producer" with superior secretion capabilities.

Step 3

High-Fidelity Precision Fermentation

Employing state-of-the-art digital twin modeling on a large scale, we maintain optimal metabolic flux and minimize inclusion body formation throughout fermentation.

Outcome: A robust, scalable, and highly efficient fermentation process.

Step 4

Downstream Purification & Kinetic Validation

We use multi-step chromatography for enzyme isolation, followed by real-time NMR or HPLC to rigorously confirm the absence of unwanted decarboxylation byproducts.

Outcome: An ultra-pure, high-activity enzyme preparation with exceptional quality standards.

Fig.2. UDP-Glucuronic acid 4-epimerase production workflow. (Creative Biolabs AI) Fig.2 Production of UDP-glucuronic acid 4-epimerase.

Application

Food Science & Nutraceutical Engineering

Our UDP-glucuronic acid 4-epimerase service drives breakthroughs in food science by enabling the enzymatic synthesis of structurally defined pectic polysaccharides. These biopolymers, critical for gelling, emulsification, and fiber enrichment, are produced with unprecedented control over molecular architecture, enhancing food texture, shelf-life, and bioactive potential while reducing reliance on chemical extraction methods.

Biopharmaceutical Development

In the realm of biopharmaceuticals, our epimerase facilitates the site-specific incorporation of galacturonic acid into therapeutic proteins, enabling the design of bio-identical molecules with optimized mechanical stability and sensory profiles. This glycoengineering approach addresses key challenges in alternative protein development, such as improving texture, solubility, and immunogenicity, paving the way for sustainable, high-performance biotherapeutics.

Advanced Therapeutics

For antibody-based therapies, precise control over UDP-GlcA-to-UDP-GalA conversion is essential for generating homogeneous glycoforms with enhanced pharmacokinetic properties. Our epimerase technology ensures consistent glycosylation patterns, boosting antibody stability, serum half-life, and target affinity-critical factors for clinical success in oncology, immunology, and infectious disease treatments.

Industrial Biotechnology

Leveraging our epimerase's high catalytic efficiency and substrate specificity, we enable cost-effective, large-scale production of glycosylated compounds in microbial systems. This advancement supports eco-friendly manufacturing of food additives, pharmaceutical intermediates, and bio-based materials, aligning with global sustainability goals.

Service Features

Dynamic Flux Analysis
Our platform integrates high-resolution structural modeling with real-time metabolic flux analysis to optimize enzyme architecture and catalytic efficiency. This ensures precise control over reaction kinetics, delivering superior conversion fidelity compared to conventional methods.

Decarboxylation Trap Elimination
Unlike standard enzymes prone to side reactions, our custom epimerases are engineered to bypass the "decarboxylation trap," ensuring complete conversion of UDP-GlcA to UDP-GalA without unwanted byproducts. This enhances product purity and simplifies downstream processing.

Digital Twin-Optimized Proteostasis
Advanced digital twin simulations enable us to optimize proteostasis and reduce ER stress during secretion in industrial-scale bioreactors. This maintains high enzyme yields and activity, ensuring consistent performance across large-volume production.

Kinetic Speed Limit Engineering
We redefine enzyme kinetics by optimizing rate-limiting binding steps and conformational transitions. Our biocatalysts outperform wild-type and animal-derived alternatives, offering superior stability, faster turnover rates, and scalability for high-demand applications.

Structural Biology-Driven Optimization
By combining structural biology insights with industrial-scale bioprocessing, we tailor enzymes to your specific process requirements. This approach bridges laboratory innovation with commercial viability, delivering robust, high-performance biocatalysts from development to full-scale manufacturing.

Customer Reviews

Pure Synthesis
"Using the custom UDP-glucuronic acid 4-epimerase in our research has facilitated the synthesis of pure UDP-GalA without the usual UDP-xylose contamination. The kinetic data provided were instrumental in our metabolic flux models."- A month ago, Dr. Sarah

High Yield
"Using the production service in our research has improved our yields of pectic polysaccharides. Their proteostasis engineering meant we didn't face the ER stress issues common with other providers."- Three weeks ago, Prof. Michael

FAQs

Q: How does your custom service prevent the common problem of enzyme instability?

A: We utilize engineering to optimize the NAD⁺-binding pocket, which enhances the thermal and chemical stability of the enzyme during storage and industrial use.

Q: Can you produce epimerases from non-conventional yeast or fungal sources?

A: Yes. Our high-throughput screening platform and Pichia pastoris expression systems are specifically designed to handle "difficult-to-express" sequences from a wide variety of evolutionary orthologs.

Q: What is the purity level of the final enzyme deliverable?

A: We typically deliver enzymes at >95% purity as determined by SDS-PAGE and HPLC. Higher purity levels for pharmaceutical applications can be requested during your initial consultation.

Q: How do you ensure the enzyme won't produce unwanted side-products like UDP-xylose?

A: Our engineering focuses on stereo-electronic constraints that prevent the labile β-keto acid intermediate from undergoing decarboxylation, ensuring high conversion fidelity to UDP-GalA.

Q: Is it possible to scale up production if our project moves to commercial manufacturing?

A: Absolutely. Our digital twin modeling and industrial-scale bioreactors ensure that the transition from custom pilot batches to metric-ton production is seamless and cost-effective.

Extended Services

Custom UDP-Galacturonic Acid Production Service

We offer a specialized and customized UDP-galacturonic acid production service, tailored precisely to meet your unique research or industrial requirements with high purity and efficiency.

Glycoengineering Services

Our glycoengineering services specialize in designing and optimizing glycosylation pathways to produce complex carbohydrates, glycoproteins, and glycolipids with precision.

At Creative Biolabs, our custom UDP-glucuronic acid 4-epimerase production service provides the molecular precision and industrial scalability required for the next generation of sustainable proteins and biopharmaceuticals. For detailed technical specifications, project timelines, or to request a quote, please reach out to our scientific strategy team.

Reference

Yin, Sen, et al. "CDNA isolation and functional characterization of UDP-d-glucuronic acid 4-epimerase family from Ornithogalum caudatum." Molecules 21.11 (2016): 1505. Distributed under an Open Access license CC BY 4.0, without modification. https://doi.org/10.3390/molecules21111505.

For Research Use Only.

Related Services

Online Inquiry